Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Factor VII antibody (AA 366-466)

The Mouse Monoclonal anti-Factor VII antibody (Clone F7-3618) (ABIN7862776) specifically detects Factor VII in IHC and ELISA. The antibody is reactive with Human samples.
Catalog No. ABIN7862776
$640.46
Plus shipping costs $50.00
Shipping to: United States
Delivery in 2 to 5 Business Days

Quick Overview for Factor VII antibody (AA 366-466) (ABIN7862776)

Target

See all Factor VII (F7) Antibodies
Factor VII (F7) (Coagulation Factor VII (F7))

Reactivity

  • 96
  • 14
  • 9
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 62
  • 40
  • 9
  • 2
  • 1
Mouse

Clonality

  • 75
  • 39
Monoclonal

Conjugate

  • 86
  • 15
  • 5
  • 4
  • 2
  • 1
  • 1
This Factor VII antibody is un-conjugated

Application

  • 66
  • 54
  • 44
  • 18
  • 17
  • 17
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), ELISA

Clone

F7-3618
  • Binding Specificity

    • 27
    • 8
    • 6
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 366-466

    Purpose

    Coagulation Factor VII / F7 Antibody

    Specificity

    Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin and Factors X, IX, V and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble Fibrin clots and the promotion of platelet aggregation. Coagulation Factor VII (serum prothrombin conversion accelerator, proconvertin, F7, Factor VII) is a 406 amino acid, vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor. Factor IX A, Factor X A, Factor XII A or Thrombin-mediated proteolytic cleavage of Factor VII at Arg 152-Ile 153 generates Factor VII A, an active serine protease composed of a catalytic heavy chain disulfide linked to a light chain, containing two EGF-like domains. Mutations at the F7 locus that lead to Factor VII deficiencies are generally asymptomatic or phenotypically uncharacterized, with hemorrhagic diathesis occurring at extremely low levels.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant fragment (around aa 366-466) of human F7 protein

    Isotype

    IgG2b, kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Expiry Date

    24 months
  • Target

    Factor VII (F7) (Coagulation Factor VII (F7))

    Alternative Name

    Coagulation Factor VII

    Background

    Eptacog alfa, Factor VII heavy chain, Factor VII light chain, FVII coagulation protein, Proconvertin, Serum prothrombin conversion accelerator (SPCA)

    Human liver or gastric carcinoma.

    Molecular Weight

    200/80/73/50/43 kDa

    Gene ID

    2155, 36989

    UniProt

    P08709

    Pathways

    Response to Growth Hormone Stimulus, Platelet-derived growth Factor Receptor Signaling
You are here:
Chat with us!